Haloperidol increases expression of the inositol 1,4,5-trisphosphate receptors in rat cardiac atria, but not in ventricles

General Physiology and Biophysics

Volumn 29, Issue 4, 2010, Pages 381-389

  Novakova, Marie ^a   Sedlakova, Barbora ^b   Sirova, Marta ^b   Fialova, Katerina ^a   Krizanova, Olga ^b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

Author keywords

Haloperidol; Inositol 1,4,5 trisphosphate receptors; Sigma 1 receptors

Indexed keywords

HALOPERIDOL; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART ATRIUM; LONG TERM CARE; MALE; MORNING DOSAGE; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; GENE EXPRESSION REGULATION; HALOPERIDOL; HEART ATRIA; HEART VENTRICLES; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MYOCYTES, CARDIAC; PC12 CELLS; RATS; RATS, WISTAR; RNA, MESSENGER;

RATTUS;

EID: 78650650909     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: 10.4149/gpb_2010_04_381     Document Type: Article

References (36)

1. Alonso G., Phan V., Guillemain I., Saunier M., Legrand A., Anoal M., Maurice T. (2000): Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience 97, 155-170; doi:10.1016/S03064522(00)00014-2
2. Barnett A. A. (1996): Safety concerens over antipsychotic drug, sertindole. Lancet 348, 256-257; doi:10.1016/S01406736(05)65549-3
3. Bermack J. E., Debonnel G. (2005): The role of sigma receptors in depression. J. Pharmacol. Sci. 97, 317-336; doi:10.1254/ jphs.CRJ04005X
4. 2+ channels in rat and mouse cultured hippocampal pyramidal neurones. Br. J. Pharmacol. 116, 2801-2810
5. 2+ influx and beating rate in cultured cardiac myocytes. J. Pharmacol. Exp. Ther. 269, 1300-1309
6. Fayer S. A. (1986): Torsades de pointes ventricular tachyarrhythmia associated with haloperidol. J. Clin. Psychopharmacol. 6, 375-376; doi:10.1097/00004714-198612000-00018
7. Fialova K., Krizanova O., Jarkovsky J., Novakova M. (2009): Apparent desensitization of the effects of sigma receptor ligand haloperidol in isolated rat and guinea pig hearts after chronic treatment. Can. J. Physiol. Pharmacol. 87, 1019-1027; doi:10.1139/Y09-066
8. Glassman A. H., Bigger J. T. Jr. (2001): Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am. J. Psychiatry 158, 1774-1782; doi:10.1176/ appi.ajp.158.11.1774
9. Henderson R. A., Lane S., Henry J. A. (1991): Life-threatening ventricular arrhythmia (torsades de pointes) after haloperidol overdose. Hum. Exp. Toxicol. 10, 59-62; doi:10.1177/096032719101000110
10. Hayashi T., Su T. P. (2001): Regulating ankyrin dynamics: Roles of sigma-1 receptors. Proc. Natl. Acad. Sci. U.S.A. 98, 491-496; doi:10.1073/pnas.021413698
11. Hayashi T., Su T. P. (2004): Sigma-1 receptor ligands: potential in the treatment of neuropsychiatrie disorders. CNS Drugs 18, 269-284; doi:10.2165/00023210-200418050-00001 (Pubitemid 38526712)
12. Hund T. J., Mohler P. J. (2008): Ankyrin-based targeting pathway regulates human sinoatrial node automaticity. Channels (Austin) 2, 404-406; doi:10.4161/chan.2.6.7220
13. Hunt N., Stern T. A. (1995): The association between intravenous haloperidol and Torsades de Pointes. Three cases and a literature review. Psychosomatics 36, 541-549
14. Ishima T., Nishimura T., Iyo M., Hashimoto K. (2008): Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP3 receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1656-1659; doi:10.1016/j.pnpbp.2008.06.011
15. Johannessen M., Ramachandran S., Reamer L., Ramos-Serrano A., Ruoho A. E., Jackson M. B. (2009): Voltage-gated sodium channel modulation by sigma-receptors in cardiac myocytes and heterologous systems. Am. J. Physiol. Cell. Physiol. 296, C1049-1057; doi:10.1152/ajpcell.00431.2008
16. Krähenbühl S., Sauter B., Kupferschmidt H., Krause M., Wyss P. A., Meier P. J. (1995): Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication. Am. J. Med. Sci. 309, 315-316; doi:10.1097/00000441-199506000-00003
17. Kriwisky M., Perry G. Y., Tarchitsky D., Gutman Y., Kishon Y. (1990): Haloperidol-induced torsades de pointes. Chest 98, 482-484; doi:10.1378/chest. 98.2.482
18. Krizanova O., Holotnakova T., Jurkovicova D., Polakova E., Zahradnikova A., Lacinova L., Kvetnanský R., Myslivecek J., Pastorekova S. (2008): Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. Ann. N.Y. Acad. Sci. 1148, 331-337; doi:10.1196/annals.1410.023
19. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. (1951): Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275
20. Malik M., Camm A. J. (1996): Correct the QT interval correctly: Should QTc be expressed in the same units as the QT interval? Pacing. Clin. Electrophysiol. 19, 1531-1534; doi:10.1111/j.1540-8159.1996.tb03176.x
21. Maurice T., Su T. P. (2009): The pharmacology of sigma-1 receptors. Pharmacol. Ther. 124, 195-206; doi:10.1016/j.pharmthera.2009.07.001
22. Metzger E., Friedman R. (1993): Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill. J. Clin. Psychopharmacol. 13, 128-132; doi:10.1097/00004714199304000-00007
23. Monassier L., Bousquet P. (2002): Sigma receptors: from discovery to highlights of their implications in the cardiovascular system. Fundam. Clin. Pharmacol. 16, 1-8; doi:10.1046/ j.1472-8206.2002.00063.x
24. Nguyen V. H., Ingram S. L., Kassiou M., Christie M. J. (1998): Sigma-binding site ligands inhibit K+ currents in rat locus coeruleus neurons in vitro. Eur. J. Pharmacol. 361, 157-163; doi:10.1016/S0014-2999(98)00706-7
25. Novakova M., Ela C., Barg J., Vogel Z., Hasin Y., Eilam Y. (1995): Inotropic action of sigma receptor ligands in isolated cardiac myocytes from adult rats. Eur. J. Pharmacol. 286, 19-30; doi:10.1016/0014-2999(95)00424-J
26. Novakova M., Ela C., Bowen W. D., Hasin Y., Eilam Y. (1998): Highly selective sigma receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes. Eur. J. Pharmacol. 353, 315-327; doi:10.1016/ S00142999(98)00398-7
27. Novakova M., Bruderova V., Sulova Z., Kopacek J., Lacinova L., Kvetnansky R., Vasku A., Kaplan P., Krizanova O., Jurkovicova D. (2007): Modulation of expression of the sigma receptors in the heart of rat and mouse in normal and pathological conditions. Gen. Physiol. Biophys. 26, 110-117
28. Pacher P., Kecskemeti V. (2004): Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr. Pharm. Des. 10, 2463-2475; doi:10.2174/ 1381612043383872
29. Pezawas L., Quiner S., Moertl D., Tauscher J., Barnas C., Küfferle B., Wolf R., Kasper S. (2000): Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance. Int. Clin. Psychopharmacol. 15, 207-214; doi:10.1097/00004850200015040-00003
30. Roman F., Pascaud X., Chomette G., Bueno L., Junien J. L. (1989): Autoradiographic localization of sigma opioid receptors in the gastrointestinal tract of the guinea pig. Gastroenterology 97, 76-82 (Pubitemid 19190999)
31. Takebayashi M., Hayashi T., Su T. P. (2002): Nerve growth factorinduced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants. J. Pharmacol. Exp. Ther. 303, 1227-1237; doi:10.1124/jpet.102. 041970
32. Takebayashi M., Hayashi T., Su T. P. (2004): Sigma-1 receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: potential relation to lipid raft reconstitution. Synapse 53, 90-103; doi:10.1002/syn.20041
33. Tokuyama S., Hirata K., Ide A., Ueda H. (1997): Sigma ligands stimulate GTPase activity in mouse prefrontal membranes: evidence for the existence of metabotropic sigma receptor. Neurosci. Lett. 233, 141-144; doi:10.1016/ S0304-3940(97)00657-5
34. Torrence-Campbell C., Bowen W. D. (1996): Differential solubilization of rat liver sigma 1 and sigma 2 receptors: retention of sigma 2 sites in particulate fractions. Eur. J. Pharmacol. 304, 201-210; doi:10.1016/0014- 2999(96)00109-4
35. Welch R., Chue P. (2000): Antipsychotic agents and QT changes. J. Psychiatry. Neurosci. 25, 154-160
36. Wolfe S. A. Jr., Culp S. G., De Souza E. B. (1989): Sigma-receptors in endocrine organs: identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary. Endocrinology 124, 1160-1172; doi:10.1210/ endo-124-3-1160